Search
for
Sort by
Research 331–360 of 1000+
- Tissue engineering of skin and regenerative medicine for wound care
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- TCF/Lef1-Mediated Control of Lipid Metabolism Regulates Skin Barrier Function
- Effective treatment with afoxolaner (NexGard) of <i>Trixacarus caviae</i> in a pet guinea pig
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Skin barrier, phenotypic and genotypic characterisation of autosomal recessive ichthyosis in TGM1‐deficient Jack Russell Terriers and response to topical ceramide
- A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements
- Sarcoidosis: Are there differences in your skin of color patients?
- Homozygous whole body <i>Cbs</i> knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia
- Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes
- Severe Lichen Planus Pigmentosus Inversus in an Elderly Female Following Intra-Articular Injections of Homeopathic Substances
- Netherton Syndrome in a 9-Month-Old Child: Unraveling a Complex Dermatologic Disorder
- Dermatological Manifestations of COVID-19 Patients
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Toxic Epidermal Necrolysis
- Management of congenital ichthyoses: European guidelines of care, part two
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Malicious Mites—Sarcoptes scabiei in Raccoon Dogs (Nyctereutes procyonoides) in Schleswig-Holstein, Germany
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- TOC
- Homozygous ALOXE3 Nonsense Variant Identified in a Patient with Non-Bullous Congenital Ichthyosiform Erythroderma Complicated by Superimposed Bullous Majocchi’s Granuloma: The Consequences of Skin Barrier Dysfunction
- Conditional epidermal expression of TGFβ1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers